期刊文献+

Increased Midkine and Estrogen Receptor-β Expression in Human Non-Small Cell Lung Cancer 被引量:1

Increased Midkine and Estrogen Receptor-β Expression in Human Non-Small Cell Lung Cancer
下载PDF
导出
摘要 Objective: Midkine (MK), a new member of the heparin-binding growth factor family, has been found recently to have a high expression level in many tumor specimens including lung carcinoma. Estrogens may be involved in lung carcinogenesis, and estrogen receptors, mainly estrogen receptor-β (ER-β), are present and functional in normal lung and tumor cell lines and tissues. In addition, estrogens and growth factors may promote the progression of human non-small cell lung cancer (NSCLC). Previously, we have immunohistochemically demonstrated that MK and ER-β proteins were overexpressed in NSCLC and their expression levels were both significantly negatively correlated with the pathological classification. The purpose of this study was to further verify their expression and its correlation with NSCLC. Methods: Taking NSCLC tissues and their corresponding paraneoplastic and normal lung as research objects, we further examined the expression of MK and ER-β by meas of RT-PCR, in situ hybridization and Western blot analyses at the levels of messenger RNA (mRNA) and protein, respectively. Results: The increased MK and ER-β mRNA expression was found in NSCLC by RT-PCR and in situ hybridization analyses. Furthermore, Western blot analysis also displayed increased expression of MK and ER-β proteins in NSCLC. Finally, their correlation analysis at the levels of mRNA and protein expression in NSCLC demonstrated that MK protein level was significantly correlated to estrogen receptor-β (P〈0.01, rs=0.535); in spite of their correlation at the mRNA level, there was no remarkable difference between MK and ER-β (P〉0.05, rs=0.178). Conclusion: All these results in the present study confirmed that MK and ER-β were overexpressed in human NSCLC. Objective: Midkine (MK), a new member of the heparin-binding growth factor family, has been found recently to have a high expression level in many tumor specimens including lung carcinoma. Estrogens may be involved in lung carcinogenesis, and estrogen receptors, mainly estrogen receptor-β (ER-β), are present and functional in normal lung and tumor cell lines and tissues. In addition, estrogens and growth factors may promote the progression of human non-small cell lung cancer (NSCLC). Previously, we have immunohistochemically demonstrated that MK and ER-β proteins were overexpressed in NSCLC and their expression levels were both significantly negatively correlated with the pathological classification. The purpose of this study was to further verify their expression and its correlation with NSCLC. Methods: Taking NSCLC tissues and their corresponding paraneoplastic and normal lung as research objects, we further examined the expression of MK and ER-β by meas of RT-PCR, in situ hybridization and Western blot analyses at the levels of messenger RNA (mRNA) and protein, respectively. Results: The increased MK and ER-β mRNA expression was found in NSCLC by RT-PCR and in situ hybridization analyses. Furthermore, Western blot analysis also displayed increased expression of MK and ER-β proteins in NSCLC. Finally, their correlation analysis at the levels of mRNA and protein expression in NSCLC demonstrated that MK protein level was significantly correlated to estrogen receptor-β (P〈0.01, rs=0.535); in spite of their correlation at the mRNA level, there was no remarkable difference between MK and ER-β (P〉0.05, rs=0.178). Conclusion: All these results in the present study confirmed that MK and ER-β were overexpressed in human NSCLC.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2009年第4期255-264,共10页 中国癌症研究(英文版)
基金 supported by a grant from General Program of the National Natural Science Foundation of China(No.30872941) the Scientific Research Foundation of Graduate School of Nanjing University(2008CL06)
关键词 Midkine (MK) Estrogen receptor-β (ER-β) Non-small cell lung cancer (NSCLC) Midkine (MK) Estrogen receptor-β (ER-β) Non-small cell lung cancer (NSCLC)
  • 相关文献

参考文献2

二级参考文献12

  • 1李鸿伟,平金良,戴利成,章步文,赵华,沈琦斌,余才华.中期因子蛋白在非小细胞肺癌中的表达及其临床意义[J].中国癌症杂志,2005,15(4):331-334. 被引量:6
  • 2Yaling Huang Guochun Cao Hui Wang Qingling Wang Yayi Hou.The Expression and Location of Midkine in Gastric Carcinomas of Chinese Patients[J].Cellular & Molecular Immunology,2007,4(2):135-140. 被引量:17
  • 3Garver RIJ,Radford DM,Donis-Keller H,Wick MR,Milner PG.Midkine and pleiotrophin expression in normal and malignant breast tissue[].Cancer.1994
  • 4O’Brien T,Cranston D,Fuggle S,Bicknell R,Harris AL.The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers[].Cancer Research.1996
  • 5Choudhuri R,Zhang HT,Donnini S,Ziche M,Bicknell R.Anangiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis[].Cancer Research.1997
  • 6Ikematsu S,Okamoto K,Yoshida Y,et al.High levels of urinary midkine in various cancer patients[].Biochemical and Biophysical Research Communications.2003
  • 7Maeda N,Ichihara-Tanaka K,Kimura T,Kadomatsu K,Muramatsu T,Noda M.A receptor-like protein-tyrosine phosphatase PTPζ/RPTPb binds a heparin-binding growth factor midkine.Involvement of arginine 78 of midkine in the high affinity binding to PTPζ[].Journal of Biological Chemistry.1999
  • 8Kadomatsu K,Tomomura M,Muramatsu T.cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid- gestation period of mouse embryogenesis[].Biochemical and Biophysical Research Communications.1988
  • 9Kadomatsu K,Hagihara M,Akhter S,Fan QW,Muramatsu H,Muramatsu T.Midkine induces the transformation of NIH3T3 cells[].British Journal of Cancer.1997
  • 10Kojima S,Muramatsu H,Amanuma H,Muramatsu T.Midkine enhances fibrinolytic activity of bovine endothelial cells[].Journal of Biological Chemistry.1995

共引文献17

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部